Amgen settles with FTC over US$28 billion deal
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Sets price band at ?695 to ?735 per Equity Share
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Subscribe To Our Newsletter & Stay Updated